Long‐term efficacy of deep brain stimulation of the subthalamic nucleus in patients with pharmacologically intractable epilepsy: A case series of six patients

Author:

Cui Zhiqiang1,Wang Jian1ORCID,Mao Zhiqi1,Ling Zhipei1,Zhang Jianning1,Chen Tong2ORCID

Affiliation:

1. Department of Neurosurgery Chinese PLA General Hospital Beijing China

2. Department of Neurology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases Chinese PLA General Hospital Beijing China

Abstract

AbstractObjectiveEpilepsy is one of the widespread neurological illnesses, and about 20%–40% of epilepsy patients are pharmacoresistant. We aimed to assess the long‐term efficacy of subthalamic nucleus (STN) deep brain stimulation (DBS) for drug‐resistant epilepsy.MethodsWe included pharmacologically intractable epilepsy patients who had STN‐DBS at the Chinese People's Liberation Army General Hospital between June 2016 and December 2018. We retrospectively evaluated pre‐ and postoperative clinical outcomes, including seizure frequency, seizure type, anti‐seizure medication, cognitive function, anatomical target coordinates, stimulation parameters, and adverse events following the surgical procedure. Six patients with a mean follow‐up of 49.3 ± 10.2 months, were included.ResultsSeizure frequency decreased by an average of 64.0% after STN‐DBS at last year follow‐up (p = .046), and one patient (1/6) achieved seizure‐free status. For seizure type, anti‐seizure medication, and cognitive function, there were no significant differences between pre‐and post‐operation (p > .05). In terms of stimulation parameters, the pulse width, amplitude, and frequency were 58.3 ± 9.4 μs, 2.5 ± .7 V, and 122.5 ± 15.7 Hz, respectively. None of the patients showed normal electroencephalography during the electroencephalography reexamination. There were no surgery‐related complications, and chronic STN stimulation was generally well tolerated in five patients. However, one patient (1/6) had a difficulty of dyskinesia in the right arm.SignificanceIn conclusion, neuromodulation of the STN by DBS is a promising option for patients with pharmacologically intractable epilepsy, especially for whose epileptic zone originates mainly from the frontoparietal region and who are unsuitable for resective surgery. Further prospective multicenter studies with a larger sample size are necessary for further exploration.

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3